|

Lumateperone Clinical Trials

3 actively recruiting trials across 3 locations

▲ +1 trial since August 2026

Also known as: Caplyta

Pipeline

Phase 3: 3

Top Sponsors

  • Intra-Cellular Therapies, Inc.2
  • Eric Lenze1

Indications

  • Depression3
  • Late Life Depression (LLD)1
  • Treatment Resistant Depression (TRD)1
  • Bipolar Depression1
  • Major Depressive Disorder1

Dothan, Alabama1 trial

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Harmonex Neuroscience Research

Phase 3

Huntsville, Alabama1 trial

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

University of Alabama at Birmingham

Phase 3

Tucson, Arizona1 trial

Lumateperone for Late-Life Depression

University of Arizona

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.